FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912990928> ?p ?o ?g. }

• W2912990928 endingPage "123" @default.
• W2912990928 startingPage "107" @default.
• W2912990928 abstract "Objective: The objective of this study was to provide an evaluation of the benefits and adverse effects (AEs) of psychiatric and seizure medications commonly used for individuals with autism spectrum disorder (ASD). Methods: As part of the National Survey on Treatment Effectiveness for Autism, we report ratings of 26 psychiatric and seizure medications by 505 participants. Each medication was rated with a standardized scale for overall benefits, overall AEs, and specific symptoms affected. The frequency of use and net perceived benefit (overall benefit minus overall AE) are reported. Results: Most medications were rated as having a slightly greater benefit than AE. Six medications (lamotrigine, oxcarbazepine, clonidine, guanfacine, buspirone, and sertraline) had benefit ratings that were more than twice their adverse rating. Conversely, some medications had slightly negative net benefit ratings (worse AEs than benefits on average), including Adderall, Paroxetine, Quetiapine, Olanzapine, and Topiramate. However, there were wide variations in individual ratings of benefit and AEs, suggesting that clinical response to medications was highly variable, so these scores simply represent averages. A ranking of the top medications (those with the highest net perceived benefit) for each of 18 different symptoms is provided, which may provide some clinical guidance as to which medications may be most worth considering for a given symptom. A comparison of the survey results with the results of clinical trials shows generally good agreement in terms of medication benefits with some differences; in some cases the differences are because the clinical trials did not assess all of the symptoms assessed by this survey. Conclusions: It is hoped that physicians and their patients will find the survey results useful in selecting the most promising medications for a given symptom, and also for monitoring for likely benefits and AEs, especially for medications for which few or no studies have been carried out in ASD populations." @default.
• W2912990928 created "2019-02-21" @default.
• W2912990928 creator A5021143842 @default.
• W2912990928 creator A5026988296 @default.
• W2912990928 creator A5051007027 @default.
• W2912990928 creator A5088962222 @default.
• W2912990928 date "2019-03-01" @default.
• W2912990928 modified "2023-10-10" @default.
• W2912990928 title "Rating of the Effectiveness of 26 Psychiatric and Seizure Medications for Autism Spectrum Disorder: Results of a National Survey" @default.
• W2912990928 cites W1555175985 @default.
• W2912990928 cites W1906903025 @default.
• W2912990928 cites W1970038529 @default.
• W2912990928 cites W1972902860 @default.
• W2912990928 cites W1986023481 @default.
• W2912990928 cites W1989094904 @default.
• W2912990928 cites W2028478180 @default.
• W2912990928 cites W2042073330 @default.
• W2912990928 cites W2055607877 @default.
• W2912990928 cites W2063988263 @default.
• W2912990928 cites W2066817339 @default.
• W2912990928 cites W2076733246 @default.
• W2912990928 cites W2078189481 @default.
• W2912990928 cites W2094231220 @default.
• W2912990928 cites W2104597960 @default.
• W2912990928 cites W2116795013 @default.
• W2912990928 cites W2119763231 @default.
• W2912990928 cites W2126273841 @default.
• W2912990928 cites W2145885076 @default.
• W2912990928 cites W2150186622 @default.
• W2912990928 cites W2156712014 @default.
• W2912990928 cites W2169588646 @default.
• W2912990928 cites W2280843891 @default.
• W2912990928 cites W2300412237 @default.
• W2912990928 cites W2312870890 @default.
• W2912990928 cites W2413684047 @default.
• W2912990928 cites W2430058236 @default.
• W2912990928 cites W2440939746 @default.
• W2912990928 cites W2602801922 @default.
• W2912990928 cites W2756718375 @default.
• W2912990928 cites W749806508 @default.
• W2912990928 doi "https://doi.org/10.1089/cap.2018.0121" @default.
• W2912990928 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6442266" @default.
• W2912990928 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30724573" @default.
• W2912990928 hasPublicationYear "2019" @default.
• W2912990928 type Work @default.
• W2912990928 sameAs 2912990928 @default.
• W2912990928 citedByCount "39" @default.
• W2912990928 countsByYear W29129909282019 @default.
• W2912990928 countsByYear W29129909282020 @default.
• W2912990928 countsByYear W29129909282021 @default.
• W2912990928 countsByYear W29129909282022 @default.
• W2912990928 countsByYear W29129909282023 @default.
• W2912990928 crossrefType "journal-article" @default.
• W2912990928 hasAuthorship W2912990928A5021143842 @default.
• W2912990928 hasAuthorship W2912990928A5026988296 @default.
• W2912990928 hasAuthorship W2912990928A5051007027 @default.
• W2912990928 hasAuthorship W2912990928A5088962222 @default.
• W2912990928 hasBestOaLocation W29129909281 @default.
• W2912990928 hasConcept C118552586 @default.
• W2912990928 hasConcept C126322002 @default.
• W2912990928 hasConcept C138496976 @default.
• W2912990928 hasConcept C15744967 @default.
• W2912990928 hasConcept C197934379 @default.
• W2912990928 hasConcept C205778803 @default.
• W2912990928 hasConcept C2776412080 @default.
• W2912990928 hasConcept C2776619155 @default.
• W2912990928 hasConcept C2777669559 @default.
• W2912990928 hasConcept C2777683783 @default.
• W2912990928 hasConcept C2778186239 @default.
• W2912990928 hasConcept C2778538070 @default.
• W2912990928 hasConcept C2778802184 @default.
• W2912990928 hasConcept C2779177272 @default.
• W2912990928 hasConcept C2779253243 @default.
• W2912990928 hasConcept C2780634440 @default.
• W2912990928 hasConcept C2781176495 @default.
• W2912990928 hasConcept C558461103 @default.
• W2912990928 hasConcept C70410870 @default.
• W2912990928 hasConcept C71924100 @default.
• W2912990928 hasConcept C83849319 @default.
• W2912990928 hasConceptScore W2912990928C118552586 @default.
• W2912990928 hasConceptScore W2912990928C126322002 @default.
• W2912990928 hasConceptScore W2912990928C138496976 @default.
• W2912990928 hasConceptScore W2912990928C15744967 @default.
• W2912990928 hasConceptScore W2912990928C197934379 @default.
• W2912990928 hasConceptScore W2912990928C205778803 @default.
• W2912990928 hasConceptScore W2912990928C2776412080 @default.
• W2912990928 hasConceptScore W2912990928C2776619155 @default.
• W2912990928 hasConceptScore W2912990928C2777669559 @default.
• W2912990928 hasConceptScore W2912990928C2777683783 @default.
• W2912990928 hasConceptScore W2912990928C2778186239 @default.
• W2912990928 hasConceptScore W2912990928C2778538070 @default.
• W2912990928 hasConceptScore W2912990928C2778802184 @default.
• W2912990928 hasConceptScore W2912990928C2779177272 @default.
• W2912990928 hasConceptScore W2912990928C2779253243 @default.
• W2912990928 hasConceptScore W2912990928C2780634440 @default.
• W2912990928 hasConceptScore W2912990928C2781176495 @default.
• W2912990928 hasConceptScore W2912990928C558461103 @default.
• W2912990928 hasConceptScore W2912990928C70410870 @default.

• next